Literature DB >> 24429870

Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons.

Jeffrey L Dage1, Ellen M Colvin, Antoine Fouillet, Emily Langron, William C Roell, Jingling Li, Sachin X Mathur, Adrian J Mogg, Matthew G Schmitt, Christian C Felder, Kalpana M Merchant, John Isaac, Lisa M Broad, Emanuele Sher, Daniel Ursu.   

Abstract

INTRODUCTION: Genetic causes, or predisposition, are increasingly accepted to be part of the ethiopathogenesis of many neuropsychiatric diseases. While genes can be studied in any type of cells, their physiological function in human brain cells is difficult to evaluate, particularly in living subjects.
METHODS: As a first step towards the characterisation of human inducible pluripotent stem cell (iPSC)-derived neurons from autism spectrum disorder (ASD) patients, we used gene expression and functional studies to define the regional identity of the typical forebrain differentiation, demonstrate expression patterns of genes of interest in ASD and understand the properties of 'control' iPSC-derived neurons (iCell-Neurons™), with a focus on receptors and ion channels that play a central role in synaptic physio-pathology. RESULTS AND DISCUSSION: The gene expression profile of the iCell-Neurons™ closely resembled that observed in neonatal prefrontal cortex tissues. Functional studies, performed mainly using calcium flux assays, demonstrated the presence of ionotropic glutamate (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl-D-aspartate) and gamma-aminobutyric acid type A receptors. Voltage-gated sodium and calcium channels were also identified using similar techniques.
CONCLUSIONS: Overall, the results reported here suggest that iCell-Neurons™ are a good cellular model of a relatively immature forebrain human neuron population that can be used both as a control in comparison to patients cells, and as host cells in which mutations, insertions and deletions can be used in order to study the molecular mechanisms of ASD and other neurological disorders in an isogenic cellular background.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24429870     DOI: 10.1007/s00213-013-3384-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  69 in total

1.  Neuron number and size in prefrontal cortex of children with autism.

Authors:  Eric Courchesne; Peter R Mouton; Michael E Calhoun; Katerina Semendeferi; Clelia Ahrens-Barbeau; Melodie J Hallet; Cynthia Carter Barnes; Karen Pierce
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

2.  CACNA1C (rs1006737) is associated with schizophrenia.

Authors:  M Nyegaard; D Demontis; L Foldager; A Hedemand; T J Flint; K M Sørensen; P S Andersen; M Nordentoft; T Werge; C B Pedersen; D M Hougaard; P B Mortensen; O Mors; A D Børglum
Journal:  Mol Psychiatry       Date:  2010-02       Impact factor: 15.992

3.  Rapid bidirectional switching of synaptic NMDA receptors.

Authors:  Camilla Bellone; Roger A Nicoll
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

4.  AMPA-induced Ca(2+) influx in cultured rat cortical nonpyramidal neurones: pharmacological characterization using fura-2 microfluorimetry.

Authors:  Wolfgang Fischer; Heike Franke; Peter Scheibler; Clemens Allgaier; Peter Illes
Journal:  Eur J Pharmacol       Date:  2002-03-01       Impact factor: 4.432

5.  EU-AIMS: a boost to autism research.

Authors:  Declan Murphy; Will Spooren
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

6.  Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.

Authors:  J Zhong; S L Russell; D B Pritchett; P B Molinoff; K Williams
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

7.  Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors.

Authors:  Antonio Sanz-Clemente; Jose A Matta; John T R Isaac; Katherine W Roche
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

8.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

9.  Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging.

Authors:  D F Owens; L H Boyce; M B Davis; A R Kriegstein
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

10.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

View more
  30 in total

1.  Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells.

Authors:  Xin Wang; Mei Xu; Jacqueline A Frank; Zun-Ji Ke; Jia Luo
Journal:  Toxicol Appl Pharmacol       Date:  2017-02-11       Impact factor: 4.219

2.  Ketamine Increases Proliferation of Human iPSC-Derived Neuronal Progenitor Cells via Insulin-Like Growth Factor 2 and Independent of the NMDA Receptor.

Authors:  Alessandra Grossert; Narges Zare Mehrjardi; Sarah J Bailey; Mark A Lindsay; Jürgen Hescheler; Tomo Šarić; Nicole Teusch
Journal:  Cells       Date:  2019-09-24       Impact factor: 6.600

3.  High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures.

Authors:  Oksana Sirenko; Jayne Hesley; Ivan Rusyn; Evan F Cromwell
Journal:  Assay Drug Dev Technol       Date:  2014 Nov-Dec       Impact factor: 1.738

Review 4.  Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System.

Authors:  Joshua G Hunsberger; Anastasia G Efthymiou; Nasir Malik; Mamta Behl; Ivy L Mead; Xianmin Zeng; Anton Simeonov; Mahendra Rao
Journal:  Stem Cells Dev       Date:  2015-04-20       Impact factor: 3.272

5.  Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.

Authors:  Madelyn A Gillentine; Jiani Yin; Aleksandar Bajic; Ping Zhang; Steven Cummock; Jean J Kim; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2017-11-09       Impact factor: 11.025

6.  Characterization of Functional Primary Cilia in Human Induced Pluripotent Stem Cell-Derived Neurons.

Authors:  Daisuke Miki; Yuki Kobayashi; Tomoya Okada; Tatuso Miyamoto; Nobuyuki Takei; Yuko Sekino; Noriko Koganezawa; Tomoaki Shirao; Yumiko Saito
Journal:  Neurochem Res       Date:  2019-04-29       Impact factor: 3.996

7.  An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack KNa Currents.

Authors:  Imran H Quraishi; Shani Stern; Kile P Mangan; Yalan Zhang; Syed R Ali; Michael R Mercier; Maria C Marchetto; Michael J McLachlan; Eugenia M Jones; Fred H Gage; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2019-07-26       Impact factor: 6.167

Review 8.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

9.  Characterization of neurite dystrophy after trauma by high speed structured illumination microscopy and lattice light sheet microscopy.

Authors:  Jack K Phillips; Sydney A Sherman; Kristen Y Cotton; John M Heddleston; Aaron B Taylor; John D Finan
Journal:  J Neurosci Methods       Date:  2018-12-06       Impact factor: 2.390

Review 10.  The Influence of the Val66Met Polymorphism of Brain-Derived Neurotrophic Factor on Neurological Function after Traumatic Brain Injury.

Authors:  John D Finan; Shreya V Udani; Vimal Patel; Julian E Bailes
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.